CASE CCC IN THE NEWS
University Hospitals, Philips Healthcare Align as Charter Tenant of Global Center for Health Innovation
Cleveland Business Connects Magazine- May 2013
Pablo Ros, MD, professor and chairman of the department of radiology at UH Case Medical Center and Case Western Reserve University, says UH and Phillips will use their third-floor exhibit space to highlight the lifesaving innovations that have and continue to result from their long-standing association.
New Prostate Cancer Test First Studied at Cleveland Clinic Helps Predict Cancer Risk
Plain Dealer - May 8, 2013
"This is really a boon for patients," said urologist Dr. Eric Klein, chairman of the Glickman Urological and Kidney Institute at the Clinic who oversaw the research. Klein said he hopes the new test will address the reluctance that many patients have when given the option to "watch and wait," and the reluctance many physicians have of offering that option.
The Race on Mother's Day, to Raise Money for Breast Cancer Research, is May 12 at Legacy Village in Lyndhurst
Plain Dealer - May 8, 2013
"We are incredibly proud and thankful to be associated with The Race," said Dr. Lyndsay Harris, director of the Breast Cancer Program at University Hospitals Seidman Cancer Center.
Intermittent ADT Failed to Improve Survival in Metastatic Prostate Cancer
Helio/HemOnc Today - Apr 30, 2013
Perspective by Robert Dreicer, MD, FACP, FASCO...Long before prospective trial data was available, many clinicians embraced the concept of intermittent androgen deprivation therapy (ADT).
MARK YOUR CALENDARS
Breast Cancer 2013: Seeing the Future
Registration is open for Breast Cancer 2013: Seeing the Future, Friday, May 24 at the Doubletree by Hilton Cleveland East Beachwood.
This course has a focus on the future of breast cancer treatment and how research shapes our progress. Early detection of breast cancer and then managing all stages of the disease is a rapidly changing field that remains a challenge for primary care physicians, gynecologists and breast cancer specialists. Advances in cancer genetics and genomics are guiding more of our interventions. Recent advances have changed the practice of removing axillary lymph nodes, once a standard in breast cancer treatment. Male breast cancer is rare and involves a different paradigm than female breast cancer. You will have the opportunity to speak with male breast cancer survivors at this conference. All care providers will benefit from new understanding of how to support families of cancer patients.
Race for the Place- Join Our Team!
The Race for the Place, an event that benefits the Gathering Place, will be held Sunday, June 2 at Beachwood Place Mall. The Case CCC has created a team. Click here to join the team or to show your support by making a donation. Contact Gillian Todd for more information.
Impact of Genomics on Cancer Diagnosis and Treatment: Open Drug Policy Forum
The Case CCC, in partnership with five other Midwest comprehensive cancer centers, will convene a public forum on the emerging revolution in genetic testing known as precision or personalized medicine on Monday, June 10. Experts from the government, pharmaceutical and insurance industries, public health sector, and the cancer research community will participate in dynamic lectures and discussions to consider the complexities of integrating genetic testing into cancer care.
This forum is free and open to the public. Pre-registration is required: http://goo.gl/xEuwA.
Planned discussions include:
Keynote Address: How Genomics May Transform Cancer Care
Arul Chinnaiyan, MD, PhD
How to Validate Genomic Based Decision Making in Cancer
Moderator: Sanford Markowitz, MD, PhD
Panel Members: Carl Morrison, DVM, MD; Robert J. Penny, MD, PhD; Michael A. Tainsky, PhD
Implications for Public Policy-Discussion with Congressional Representatives and NCI/FDA
Moderator: Donald L. Trump, MD
Panel Members: James H. Doroshow, MD; Stanton L. Gerson, MD; Elizabeth A. Mansfield, PhD; Anthony Murgo, MD, MS; Richard Schilsky, MD; Mikkael Sekeres, MD, MS
Challenges for the FDA and CMS: Drug Approval and Reimbursement for Off-label Drug Use for Cancer Genetic Alteration
Moderator: Richard Schilsky, MD
Panel Members: James H. Doroshow, MD; Martine George, MD, MSc; Elizabeth A. Mansfield, PhD; Neal Meropol, MD; Anthony Murgo, MD, MS
Genomics and Drug Reimbursement: White Paper from the Cleveland Forum 2013
Moderator: Stanton L. Gerson, MD
Panel Members: Brian Bolwell, MD; Richard Schilsky, MD; Donald L. Trump, MD; Max S. Wicha, MD
Implementing Proper Use of Genomic Tests to Select Therapeutics
Moderator: Lyndsay Harris, MD
Panel Members: James H. Doroshow, MD, Candace S. Johnson, PhD; Patricia M. LoRusso, DO
More information is on the Cancer Center site.
Annual Scientific Retreat
The Annual Cancer Center Scientific Retreat will commence the evening of Thursday, July 11 with a speaker and reception in the Wolstein Research Building Auditorium. The Retreat will continue the next day, Friday, July 12, at Corporate College East. The agenda is still be finalized. Details will be circulated soon!
Mesothelioma Applied Research Foundation Research Grant Funding
The Mesothelioma Applied Research Foundation (Meso Foundation) is calling for applications for its 2013 round of mesothelioma research grant funding. The Meso Foundation offers research grants for two years up to $50,000 per year. Eligible projects may relate to benchwork, translational or clinical research that is not presently funded or pending review and may be conducted through any not-for-profit academic, medical or research institution.
Deadline: August 2